(PG) Procter & Gamble - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7427181091
PG EPS (Earnings per Share)
PG Revenue
PG: Personal care, Grooming, Health, Home care, Baby products
The Procter & Gamble Company is a multinational consumer goods corporation that operates globally, offering a diverse portfolio of branded products across various categories. The companys business is segmented into five key areas: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care, each with a range of well-established brands that cater to different consumer needs.
P&Gs product portfolio includes iconic brands such as Head & Shoulders, Pantene, Gillette, Tide, Pampers, and Olay, among others. These brands are sold through various channels, including mass merchandisers, e-commerce platforms, grocery stores, and specialty stores, allowing the company to reach a wide customer base. The companys strong brand presence and diversified product offerings enable it to maintain a stable market position.
From a technical analysis perspective, the stocks current price is $169.89, above its 20-day and 50-day simple moving averages (SMA) of $162.89 and $164.02, respectively. The stock is also above its 200-day SMA of $166.75, indicating a potential uptrend. The average true range (ATR) is 3.11, representing a 1.83% daily price movement. With the 52-week high and low at $177.47 and $156.59, respectively, the stock is currently trading near the middle of its 52-week range.
Considering the fundamental data, Procter & Gamble has a market capitalization of $398.31 billion, with a price-to-earnings (P/E) ratio of 26.75 and a forward P/E of 24.27. The companys return on equity (RoE) is 30.15%, indicating a strong ability to generate profits. Based on the technical and fundamental data, a potential forecast is that the stock may continue its upward trend, potentially reaching the resistance level of $174.4 or higher, driven by the companys stable brand presence and diversified product offerings. However, a decline below the support level of $164.9 could indicate a reversal in the trend.
Additional Sources for PG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PG Stock Overview
Market Cap in USD | 384,551m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1970-01-01 |
PG Stock Ratings
Growth Rating | 50.6 |
Fundamental | 69.5 |
Dividend Rating | 63.1 |
Rel. Strength | -11.5 |
Analysts | 4.04 of 5 |
Fair Price Momentum | 161.59 USD |
Fair Price DCF | 137.48 USD |
PG Dividends
Dividend Yield 12m | 2.50% |
Yield on Cost 5y | 3.95% |
Annual Growth 5y | 4.90% |
Payout Consistency | 99.5% |
Payout Ratio | 60.4% |
PG Growth Ratios
Growth Correlation 3m | -21% |
Growth Correlation 12m | -3.9% |
Growth Correlation 5y | 89.2% |
CAGR 5y | 9.20% |
CAGR/Max DD 5y | 0.39 |
Sharpe Ratio 12m | 0.73 |
Alpha | -6.89 |
Beta | 0.190 |
Volatility | 18.46% |
Current Volume | 4681.1k |
Average Volume 20d | 6334.9k |
As of June 15, 2025, the stock is trading at USD 160.28 with a total of 4,681,056 shares traded.
Over the past week, the price has changed by -2.28%, over one month by +0.98%, over three months by -4.32% and over the past year by -1.31%.
Yes, based on ValueRay´s Fundamental Analyses, Procter & Gamble (NYSE:PG) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 69.46 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PG is around 161.59 USD . This means that PG is currently overvalued and has a potential downside of 0.82%.
Procter & Gamble has received a consensus analysts rating of 4.04. Therefor, it is recommend to buy PG.
- Strong Buy: 11
- Buy: 5
- Hold: 8
- Sell: 1
- Strong Sell: 0
According to our own proprietary Forecast Model, PG Procter & Gamble will be worth about 175 in June 2026. The stock is currently trading at 160.28. This means that the stock has a potential upside of +9.21%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 172.9 | 7.9% |
Analysts Target Price | 171.8 | 7.2% |
ValueRay Target Price | 175 | 9.2% |